Recombinant polymers for drug delivery

Polymeric Drug Delivery Systems

Volumn , Issue , 2005, Pages 417-454

  Megeed, Zaki ^a   Ghandehari, Hamidreza ^a  

^a UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78649846667     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (63)

1. Cappello J, Crissman J, Dorman M, Mikolajczak M, Textor G, Marquet M, Ferrari F. Genetic engineering of structural protein polymers. Biotechnol Prog 1990; 6:198-202.
2. Cappello J. In: Wiseman DM, ed. Handbook of Biodegradable Polymers. Amsterdam: Harwood Academic Publishers, 1997: 387-416.
3. Ferrari F, Richardson C, Chambers J, Causey SC, Pollock TJ, Cappello J, Crissman JW. US Patent 5,243,038.
4. Ferrari F, Cappello J. In: Kaplan DL, ed. Protein-Based Materials. Boston: Birkhauser, 1997:37-60.
5. Lohe AR, Brutlag DL. Multiplicity of satellite DNA sequences in Drosophila melanogaster. Proc Natl Acad Sci USA 1986; 83:696-700.
6. Sadler JR, Tecklenburg M, Betz JL. Plasmids containing many tandem copies of a synthetic lactose operator. Gene 1980; 8: 279-300.
7. Carlson M, Brutlag D. Cloning and characterization of a complex satellite DNA from Drosophila melanogaster. Cell 1977; 11:371-381.
8. Sambrook J, Russell SJ. Molecular Cloning: A Laboratory Manual, 3rd ed., Cold Spring Harbor Laboratory, 2001.
9. Meyer DE, Chilkoti A. Genetically encoded synthesis of proteinbased polymers with precisely specified molecular weight and sequence by recursive directional ligation: examples from the elastin-like polypeptide system. Biomacromolecules 2002; 3: 357-367.
10. Won JI, Barron AE. A new cloning method for the preparation of long repetitive polypeptides without a sequence requirement. Macromolecules 2002; 35:8281-8287.
11. McMillan RA, Lee TAT, Conticello VP. Rapid assembly of synthetic genes encoding protein polymers. Macromolecules 1999; 32:3643-3648.
12. Goeden-Wood NL, Conticello VP, Muller SJ, Keasling JD. Improved assembly of multimeric genes for the biosynthetic production of protein polymers. Biomacromolecules 2002; 3: 874-879.
13. Cappello J, Ferrari FA, Buerkle TL, Textor G. Purification of structurally ordered recombinant protein polymers. US Patent No. 5,235,041 (1993).
14. McPherson DT, Xu J, Urry DW. Product purification by reversible phase transition following Escherichia coli expression of genes encoding up to 251 repeats of the elastomeric pentapeptide GVGVP. Protein Exp Purif 1996; 7:51-57.
15. Meyer DE, Chilkoti A. Purification of recombinant proteins by fusion with thermally-responsive polypeptides. Nat Biotechnol 1999; 17:1112-1115.
16. Kiick KL, Saxon E, Tirrell DA, Bertozzi CR. Incorporation of azides into recombinant proteins for chemoselective modification by the Staudinger ligation. Proc Natl Acad Sci USA 2002; 99:19-24.
17. Maeda H, Fang J, Inutsuka T, Kitamoto Y. Vascular permeability enhancement in solid tumor: various factors, mechanisms involved and its implications. Int Immunopharmacol 2003; 3:319-328.
18. Urry DW, Harris CM, Luan CX, Luan C-H, Channe Gowda D, Parker TM, Peng SQ, Xu J. In: Park K, ed. Controlled Drug Delivery: Challenges and Strategies. Washington, DC: American Chemical Society, 1997, 405-438.
19. Urry DW. Physical chemistry of biological free energy transduction as demonstrated by elastic protein-based polymers. J Phys Chem B 1997; 101:11007-11028.
20. Wright ER, Conticello VP. Self-assembly of block copolymers derived from elastin-mimetic polypeptide sequences. Adv Drug Delivery Rev 2002; 54:1057-1073.
21. Chilkoti A, Dreher MR, Meyer DE. Design of thermally responsive, recombinant polypeptide carriers for targeted drug delivery. Adv Drug Delivery Rev 2002; 54:1093-1111.
22. Meyer DE, Kong GA, Dewhirst MW, Zalutsky MR, Chilkoti A. Targeting a genetically engineered elastin-like polypeptide to solid tumors by local hyperthermia. Cancer Res 2001; 61: 1548-1554.
23. Maeda H, Seymour LW, Miyamoto Y. Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo. Bioconjug Chem 1992; 3:351-362.
24. Feyerabend T, Steeves R, Wiedemann GJ, Richter E, Robins HI. Rationale and clinical status of local hyperthermia, radiation, and chemotherapy in locally advanced malignancies. Anticancer Res 1997; 17:2895-2897.
25. Raucher D, Chilkoti A. Enhanced uptake of a thermally responsive polypeptide by tumor cells in response to its hyperthermiamediated phase transition. Cancer Res 2001; 61:7163-7170.
26. Meyer DE. Drug targeting using thermally responsive polymers and local hyperthermia. J Contr Rel 2001; 74: 213-224.
27. Dreher MR, Raucher D, Balu N, Colvin OM, Ludeman SM, Chilkoti A. Evaluation of an elastin-like polypeptide-doxorubicin conjugate for cancer therapy. J Contr Rel 2003; 91:31-43.
28. Chilkoti A, Dreher MR, Meyer DE, Raucher D. Targeted drug delivery by thermally responsive polymers. Adv Drug Delivery Rev 2002; 54:613-630.
29. Harada-Shiba M, Yamauchi K, Harada A, Takamisawa I, Shimokado K, Kataoka K. Polyion complex micelles as vectors in gene therapy-pharmacokinetics and in vivo gene transfer. Gene Ther 2002; 9:407-414.
30. Lee TAT, Cooper RP, Apkarian VP, Conticello VP. Thermoreversible self-assembly of nanoparticles derived from elastin-mimetic polypeptides. Adv Mater 2000; 12:1105-1110.
31. Zhou Y, Conticello VP. Thermally responsive amphiphilic block copolymers for drug delivery. Polym Preprints 2000; 41: 1643-1644.
32. Hennink WE, van Nostrum CF. Novel crosslinking methods to design hydrogels. Adv Drug Delivery Rev 2002; 54:13-36.
33. Park K, ed. Recent developments in hydrogels. Adv Drug Delivery Rev 2002; 54:1-165.
34. Wright ER, McMillan RA, Cooper A, Apkarian RP, Conticello VP. Thermoplastic elastomer hydrogels via self-assembly of an elatin-mimetic triblock polypeptide. Adv Funct Mater 2002; 2: 149-154.
35. Cappello J, Ferrari F. In: Mobley DP, ed. Plastics from Microbes. Munich: Hanser Publishers, 1994:35-92.
36. Anderson JP, Cappello J, Martin DC. Morphology and primary crystal structure of a silk-like protein polymer synthesized by genetically engineered Escherichia coli bacteria. Biopolymers 1994; 34:1049-1058.
37. Anderson JP. Morphology and crystal structure of a recombinant silk-like molecule, SLP4. Biopolymers 1998; 45: 307-321.
38. Megeed Z, Cappello J, Ghandehari H. Genetically engineered silk-elastinlike protein polymers for controlled drug delivery. Adv Drug Delivery Rev 2002; 54:1075-1091.
39. Cappello J, Crissman JW, Crissman M, Ferrari FA, Textor G, Wallis O, Whitledge JR, Zhou X, Burman D, Aukerman L, Stedronsky ER. In-situ self-assembling protein polymer gel systems for administration, delivery, and release of drugs. J Contr Rel 1998; 53:105-117.
40. Megeed Z, Cappello J, Ghandehari H. Controlled release of plasmid DNA from a genetically engineered silk-elastinlike hydrogel. Pharm Res 2002; 19:954-959.
41. Dinerman AA, Cappello J, Ghandehari H, Hoag SW. Solute diffusion in genetically engineered silk-elastinlike protein polymer hydrogels. J Contr Rel 2002; 82:277-287.
42. Dinerman AA, Cappello J, Ghandehari H, Hoag SW. Swelling behavior of a genetically engineered silk-elastinlike protein polymer hydrogel. Biomaterials 2002; 23:4203-4210.
43. Urry DW, Harris CM, Luan CX, Luan C-H, Channe D Gowda, Parker TM, Peng SQ, Xu J. I Park K, ed. Controlled Drug Delivery: Challenges and Strategies. Washington, DC: American Chemical Society, 1997:405-438.
44. Fu JC, Hagemeir C, Moyer DL. A unified mathematical model for diffusion from drug-polymer composite tablets. J Biomed Mater Res 1976; 10:743-758.
45. Siepmann J, Ainaoui A, Vergnaud JM, Bodmeier R. Calculation of the dimensions of drug-polymer devices based on diffusion parameters. J Pharm Sci 1998; 87:827-832.
46. Wang K, Forbes JG, Jin AJ. Single molecule measurements of titin elasticity. Prog Biophys Mol Biol 2001; 77:1-44.
47. Wang C, Stewart RJ, Kopecek J. Hybrid hydrogels assembled from synthetic polymers and coiled-coil protein domains. Nature 1999; 397:417-420.
48. Wang C, Kopecek J, Stewart RJ. Hybrid hydrogels crosslinked by genetically engineered coiled-coil block proteins. Biomacromolecules 2001; 2:912-920.
49. Yu YB. Coiled-coils: stability, specificity, and drug delivery potential. Adv Drug Delivery Rev 2002; 54:1113-1129.
50. Megeed ZE, Haider M, Li D, O’Malley BW, Cappello J, Ghandehari H. In vitro and in vivo evaluation of recombinant silk-elastinlike hydrogels for cancer gene therapy. J Contr Rel 2004; 94:433-445.
51. Xu LN, Pirollo KF, Chang EH. Transferrin-liposome-mediated p53 sensitization of squamous cell carcinoma of the head and neck to radiation in vitro. Hum Gene Ther 1997; 8:467-475.
52. Chen ZY, Yant SR, He CY, Meuse L, Shen S, Kay MA. Linear DNAs concatemerize in vivo and result in sustained transgene expression in mouse liver. Mol Ther 2001; 3:403-410.
53. Bergan D, Galbraith T, Sloane DL. Gene transfer in vitro and in vivo by cationic lipids is not significantly affected by levels of supercoiling of a reporter plasmid. Pharm Res 2000; 17: 967-973.
54. Hacein-Bey-Abina S, von Kalle C, Schmidt M, Le Deist F, Wulffraat N, McIntyre E, Radford I, Villeval JL, Fraser CC, Cavazzana-Calvo M, Fischer A. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. New Engl J Med 2003; 348:255-256.
55. Kalyanasundaram S, Feinstein S, Nicholson JP, Leong KW, Garver RI Jr. Coacervate microspheres as carriers of recombinant adenoviruses. Cancer Gene Ther 1999; 6:107-112.
56. Chandler LA, Doukas J, Gonzalez AM, Hoganson DK, Gu DL, Ma C, Nesbit M, Crombleholme TM, Herlyn M, Sosnowski BA, Pierce GF. FGF2-targeted adenovirus encoding plateletderived growth factor-β enhances de novo tissue formation. Mol Ther 2000; 2:153-160.
57. Doukas J, Chandler LA, Gonzalez AM, Gu D, Hoganson DK, Ma C, Nguyen T, Printz MA, Nesbit M, Herlyn M, Crombleholme TM, Aukerman SL, Sosnowski BA, Pierce GF. Matrix immobilization enhances the tissue repair activity of growth factor gene therapy vectors. Hum Gene Ther 2001; 12: 783-798.
58. Hosseinkhani H, Tabata Y. In vitro gene expression by cationized derivatives of an artificial protein with repeated RGD sequences, Pronectin(R). J Contr Rel 2003; 86: 169-182.
59. Cappello J. Genetic production of synthetic protein polymers. MRS Bulletin 1992; 17:48-53.
60. Panitch A, Yamaoka T, Fournier MJ, Mason TL, Tirrell DA. Design and biosynthesis of elastin-like artificial extracellular matrix proteins containing periodically spaced fibronectin cs5 domains. Macromolecules 1999; 32:1701-1703.
61. Halstenberg S, Panitch A, Rizzi S, Hall H, Hubbell JA. Biologically engineered protein-graft-poly(ethylene glycol) hydrogels: A cell adhesive and plasmin-degradable biosynthetic material for tissue repair. Biomacromolecules 2002; 3: 710-723.
62. Betre H, Setton LA, Meyer DE, Chilkoti A. Characterization of a genetically engineered elastin-like polypeptide for cartilaginous tissue repair. Biomacromolecules 2002; 3:910-916.
63. Urry DW, Parker TM, Reid MC, Gowda DC. Biocompatibility of the bioelastic materials, poly (GVGVP) and its gammairradiation cross-linked matrix -summary of generic biological test results. J Bioact Compatible Polym 1991; 6:263-282.